Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

European Union suspends Pfizer's Oxbryta for sickle cell disease due to safety concerns, urging doctors to stop use ...

"CSIR-CDRI's deep-rooted expertise in biomedical research, coupled with Zydus' innovative approach to drug discovery and ...

Terrance Drakeford, a former Paterson Healing Collective worker, was sentenced to prison in a federal case targeting a violent UpTop drug gang.

Antibody-drug conjugates (ADCs) represent a significant advancement in cancer treatment, particularly within China's burgeoning oncology sector.

A dispute over a Duchenne gene therapy highlights thorny issues surrounding FDA approvals and insurance policies.

The murder conviction stems from the death of Laura Quinn Combs, whose body was found on Nov. 3, 2022, in the woods off ...

Tagrisso, which targets exon 19 deletions or exon 21 (L858R) mutations, received the approval following a priority review.

The Motiva implants feature the patented SmoothSilk surface, engineered to improve biocompatibility and minimise inflammation ...

Emraclidine (formerly CVL-231) is a selective muscarinic M4 receptor-positive allosteric modulator (PAM) currently in two ...

Bristol-Myers Squibb shares rose in premarket trade on Friday after the U.S. Food and Drug Administration approved a schizophrenia drug. Bristol-Myers shares (BMY) jumped 6% to a five-month high in ...

MedStar executive Raj Ratwani says the idea of shared responsibility should be central to how health AI is regulated.